Contact Us | Directions | Referring a Patient

A leading comprehensive brain tumor program, using molecular diagnostic, gene expression analysis,
cutting edge clinical trials and advanced medical informatics to customize treatment plans for cancer patients.
 Latest Headlines
UHealth doctors remove brain tumor from nearly blind pregnant ...
Fri, 24 Mar 2017 00:40:00 GMT (Miami Herald)
Lawyer: JCC threat suspect's brain tumor may have led to behavior ...
Thu, 23 Mar 2017 22:56:00 GMT (CBS News)
Woman gives birth after brain tumor surgery
Fri, 24 Mar 2017 09:25:00 GMT (KWES NewsWest 9 ...)
Boy, 12, Diagnosed With Brain Tumor Right After Shaving His Head ...
Thu, 23 Mar 2017 18:26:00 GMT (Inside Edition)
New brain tumor drug
Wed, 22 Mar 2017 22:04:04 GMT (WTAJ)
Casey Cares honors teen who battled a rare brain tumor at fundraiser gala this weekend
Thu, 23 Mar 2017 21:55:59 GMT (ABC2 News)
Frisco middle school teacher battling inoperable brain tumor
Tue, 21 Mar 2017 01:37:05 GMT (Story ...)
12-Year-Old Illinois Boy Discovers He Has Brain Cancer After ...
Tue, 21 Mar 2017 14:51:50 GMT (
Antibody fights pediatric brain tumors in preclinical testing | News ...
Wed, 15 Mar 2017 19:45:48 GMT (Stanford Medical Center Report)
Student perseveres through brain tumor
Mon, 20 Mar 2017 00:56:38 GMT (The State News)
3/24/2017 9:35:26 PM
Feed cached:3/24/2017 10:51:52 PM

* Headlines are from industry sponsored news wires, medical journals and established news organizations from around the world . Please consider the source of the content when viewing the story.
Dani Saleh Brain Cancer Research Fund at UCLA

The Dani Saleh Brain Cancer Research Fund supports the brain cancer research collaboration between Dr. Timothy Cloughesy and Dr. Stan Nelson. This fund will directly support the work and training of a research fellow in Dr. Stan Nelson’s lab.

Dr. Nelson is Professor and Vice Chair of Human Genetics and Professor of Psychiatry at the David Geffen School of Medicine at UCLA.

Most Popular
. Clinical Trials
. Probe Set Analyzer
. Our Team
. Brain Tumor Translational Resource
. Art of the Brain
. Personalized Medicine using Targeted Molecular Therapy
. Online Giving
. How our Glioblastoma Multiforme Patients Perform
Neuro-Oncology on Facebook

Spring/Summer 2014
UCLA Neuro-Oncology : Breakthroughs Spotlighting new discovery in brain cancer research.

Persistent diffusion-restricted lesions in bevacizumab-treated malignant gliomas are associated with improved survival compared with matched controls.
AJNR Am J Neuroradiol

Relationship between tumor enhancement, edema, IDH1 mutational status, MGMT promoter methylation, and survival in glioblastoma.
AJNR Am J Neuroradiol

Review: molecular pathology in adult high-grade gliomas: from molecular diagnostics to target therapies.
Neuropathol Appl Neurobiol

Differential gene expression in glioblastoma defined by ADC histogram analysis: relationship to extracellular matrix molecules and survival.
AJNR Am J Neuroradiol

Comparison between intensity normalization techniques for dynamic susceptibility contrast (DSC)-MRI estimates of cerebral blood volume (CBV) in human gliomas.
J Magn Reson Imaging

All Information content hearof is designed for educational purposes only and is not for the purpose of rendering medical advice or professional services. The information provided should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. Any specific questions you may have regarding an individual's medical condition should be directed to the individual's primary care physician or other attending physician. In addition, if you have or suspect you may have a health problem, you should consult your health care provider.

Portions Copyright (Search, Chart, Content Publishing Tools, Photography, ProviderIQ) 1998-2017 SiliconMED North America

ProviderIQ is a registered trademark of SiliconMED North America and used by permission.

Copyright © 2017 UCLA Neuro-Oncology Program | Timothly Cloughesy MD; Director
All Rights Reserved.

[Content Published:3/24/2017 10:51:52 PM PST]